The use and interpretation of commercial APC gene testing for familial adenomatous polyposis

New England Journal of Medicine

Volumn 336, Issue 12, 1997, Pages 823-827

  Giardiello, Francis M ^a,d   Brensinger, Jill D ^a   Petersen, Gloria M ^a,b   Luce, Michael C ^c   Hylind, Linda M ^a   Bacon, Judith A ^a   Booker, Susan V ^a   Parker, Rodger D ^b   Hamilton, Stanley R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c LABORATORY CORPORATION OF AMERICA   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL COLON POLYPOSIS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC LINKAGE; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030901262     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199703203361202     Document Type: Article

References (29)

1. Wertz DC, Fanos JH, Reilly PR. Genetic testing for children and adolescents: who decides? JAMA 1994;272:875-81.
2. Holtzman NA. Are we ready to screen for inherited susceptibility to cancer? Oncology 1996;10:57-64.
3. Idem. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond. In: Hereditary breast, ovarian, and colon cancer. Journal of the National Cancer Institute monographs. No. 17. Washington, D.C.: Government Printing Office, 1995:95-7. (NIH publication no. 94-03837.)
4. Carter MA. Patient-provider relationship in the context of genetic testing for hereditary cancers. In: Hereditary breast, ovarian, and colon cancer. Journal of the National Cancer Institute monographs. No. 17. Washington, D.C.: Government Printing Office, 1995:119-21. (NIH publication no. 94-03837.)
5. Hubbard R, Lewontin RC. Pitfalls of genetic testing. N Engl J Med 1996;334:1192-4.
6. Brown ML, Kessler LG. The use of gene tests to detect hereditary predisposition to cancer: economic considerations. J Natl Cancer Inst 1995; 87:1131-6.
7. National Advisory Council for Human Genome Research. Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 1994;271:785.
8. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 1994; 55:i-iv.
9. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996;14:1730-6.
10. The NIH-DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research. Interim principles of the Task Force on Genetic Testing. Baltimore: Task Force on Genetic Testing, March 1996. 〈http://infonet.welch.jhu.edu/policy/genetics〉. (Also available from NAPS [document no. 05388, 33 pages], c/o Microfiche Publications, P.O. Box 3513, Grand Central Station, New York, NY 10163-3513. Remit in advance [in U.S. funds only] $11.65 for photocopies or $5 for microfiche. Outside the U.S. and Canada, add postage of $4.50 for up to 20 pages, $5.50 over 20 [$1.50 for microfiche postage]. There is a $15 invoicing charge for all orders filled before payment.)
11. National action plan on breast cancer position paper: hereditary susceptibility testing for breast cancer. J Clin Oncol 1996;14:1738-40.
12. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253: 665-9.
13. Kinzler KW, Nilbert MC, Su L-K, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.
14. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
15. Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991;66: 600-13.
16. Bussey HJR. Familial polyposis coli: family studies, histopathology, differential diagnosis, and results of treatment. Baltimore: Johns Hopkins University Press, 1975.
17. Bulow S. Familial polyposis coli. Dan Med Bull 1987;34:1-15.
18. Spirio L, Otterud B, Stauffer D, et al. Linkage of a variant or attenuated form of adenomarous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 1992;51:92-100.
19. Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991;100:1658-64.
20. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329:1982-7.
21. Petersen GM, Brensinger JD. Genetic testing and counseling in familial adenomatous polyposis. Oncology 1996;10:89-94.
22. Petersen GM. Genetic counseling and predictive genetic testing in familial adenomatous polyposis. Semin Colon Rectal Surg 1995;6:55-60.
23. Petersen GM, Boyd PA. Gene tests and counseling for colorectal cancer risk: lessons from familial polyposis. In: Hereditary breast, ovarian, and colon cancer. Journal of the National Cancer Institute monographs. No. 17. Washington, D.C.: Government Printing Office, 1995:67-71. (NIH publication no. 94-03837.)
24. Goldman L, Feinstein AR, Batsford WP, Cohen LS, Gottschalk A, Zaret BL. Ordering patterns and clinical impact of cardiovascular nuclear medicine procedures. Circulation 1980;62:680-7.
25. Goldman L, Cohn PF, Mudge GH Jr, et al. Clinical utility and management impact of M-mode echocardiography. Am J Med 1983;75: 49-56.
26. Chassin MR, Kosecoff J, Solomon DH, Brook RH. How coronary angiography is used - clinical determinants of appropriateness. JAMA 1987; 258:2543-7.
27. Kahn KL, Kosecoff J, Chassin MR, Solomon DH, Brook RH. The use and misuse of upper gastrointestinal endoscopy. Ann Intern Med 1988; 109:664-70.
28. McDonald IG, Guyatt GH, Gutman JM, Jelinek VM, Fox P, Daly J. The contribution of a non-invasive test to clinical care - the impact of echocardiography on diagnosis, management and patient anxiety. J Clin Epidemiol 1988;41:151-61.
29. Bernstein SJ, Hilborne LH, Leape LL, et al. The appropriateness of use of coronary angiography in New York State. JAMA 1993;269:766-9.